Skip to main content
. 2015 May 12;6(25):21628–21635. doi: 10.18632/oncotarget.4129

Figure 4. MiR-145 can reach xenografted tumors by intravesical injection and assessment of protein expression of miR-145-targeted and related genes in the xenografted tumor samples.

Figure 4

A. Relative expression levels of miR-145 in xenografted tumors treated with miR-145 or control miR. B. Expression of various proteins in the xenografted tumors as estimated by Western blot analysis. C. Schematic diagram of current and future studies. In this study, we showed that miR-145 could reach xenografted tumors by intravesical injection and have anti-tumor effects in our mouse model. We are comparing the anti-tumor effects between BCG and miR-145 in our mouse model now and plan to begin a clinical phase-one trial by using this system in the near future.